Because #Vitiligo is a condition much more than skin deep. This #WorldVitiligoDay Ahammune Biosciences is helping raise voices for those suffering from the condition, to remind us that it can happen to anyone and we are all in this together.

We are looking for talented individuals with passion for discovery and a zeal to succeed to join us at Pune, India. PhD with cell biology, immunology and molecular biology are welcome to apply. Please contact: [email protected], [email protected] linkedin.com/posts/vermamah…

Congrats to Parul Ganju of Ahammune Biosciences (incubatee) and Adarsha of Ayu Devices ( mentee and BIG Grantee of VentureCenter ) . Congrats to other winners too.

#Vitiligo is a common autoimmune skin disorder that affects almost 1 percent of the population globally. On this #WorldVitiligoDay, we are excited to announce a live webinar on ‘Vitiligo: Treatment and Beyond’ organized by Ahammune Biosciences Register Now - forms.gle/C3hbAJWnLZve42… #Veeda

On coming #WorldVitiligoDay, Register for the webinar on Saturday, June 25, 2022 at 2:30 PM IST. #vitiligo docs.google.com/forms/d/e/1FAI… linkedin.com/posts/vermamah… Vitiligo Risk Vitiligo NewsNetwork @UMassVitiligo VentureCenter Veeda Lifesciences Premnath V Ideaspring Capital In A Nutshell

Only a few hours to go before the registration for our #webinar on ‘Vitiligo: Treatment and Beyond’ organized by Ahammune Biosciences closes. Join us as we will be discussing about the #Vitiligo trends, treatments & a lot more. Register Now - forms.gle/C3hbAJWnLZve42… #Veeda #VitiligoDay

BIO-TECH: Ahammune Biosciences has partnered with Veeda CR for first in-human studies of its investigational new drug- AB1001, being developed as a topical therapy for #Vitiligo. More: biovoicenews.com/ahammune-biosc… via #BioVoiceNews #biotech #therapy #drugdiscovery #clinicalresearch

Tenth Portfolio Day Presentation by Ahammune Biosciences which is developing drugs targeting skin immune system and is on a journey for vitiligo treatment #Kotak #PrivateEquity #Healthcare #PortfolioDay #VentureCapital

We back women to the hilt 5F World . Here is our early investee Parul Ganju getting the Best Woman Entrepreneur Award in Singapore for Ahammune Biosciences .

SPECIAL STARTUP SERIES: In this edition, we feature Pune based Ahammune Biosciences that is working on innovative solutions for such unmet #dermatological disorders. More: biovoicenews.com/special-startu… via #BioVoiceNews #biotech #dermatology #startup #Pune VentureCenter DBT-BIRAC Department of Biotechnology

It is heartwarming to see featured the extraordinary work that IAN Group (formerly Indian Angel Network) portfolio company Ahammune Biosciences is doing to treat vitiligo, a debilitating skin pigmentation disease. Their drug candidate was recently found to have excellent safety and tolerability.

Venture Center #startup Ahammune Biosciences is the first drug discovery company in the country to develop a targeted new treatment option for #vitiligo . Delighted to share this feature on their high impact work in the The Times Of India #pune Ahammune Biosciences CSIR-IGIB CSIR-National Chemical Laboratory

This #WorldVitiligoDay on June 25th, Ahammune Biosciences invites you for the screening of a very special film – IMAGO, featuring the beautiful story of a young girl who challenges the stereotypes of beauty and embraces her life. We would be thrilled if you join us. bit.ly/ahammune

Come visit us at Global Bio India at booth E135 for amazing science and exciting discussion and learn about our experimental therapeutic solution for vitilio.

Ahammune Biosciences salutes the vitiligo warriors. To watch the full video check the link below. youtube.com/watch?v=JWBrvQ… Watch this video of Nupur Kale, a ‘Vitiligo Warrior’, urging people to look beyond their white patches and not let vitiligo stop them from living a full life.

Ahammune is ecstatic to announce its series A funding round of $5 Mn . Looking forward to an exciting next scientific phase with new partners. #piventure #drugdiscovery #vitiligo #clinicaltrials inc42.com/buzz/ahammune-…